Toxic multinodular goiter natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(20 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Toxic multinodular goiter}}
{{Toxic multinodular goiter}}
{{CMG}}; {{AE}}{{Akshun}}


{{CMG}}
==Overview==
If left untreated, toxic multinodular goiter may progress to develop [[hyperthyroidism]]. However, the progression of toxic multinodular goiter is quite slow. Untreated patients initially have a history of [[thyroid]] enlargement followed by a long period of subclinical [[hyperthyroidism]]. Overt hyperthyroidism occurs late in the course of  toxic multinodular goiter. Common [[complications]] of toxic multinodular goiter include [[tachycardia]], [[arrhythmia]], [[atrial fibrillation]], [[heart failure]] ([[dilated cardiomyopathy]]), [[pulmonary hypertension]], facial [[plethora]], inspiratory [[stridor]], [[hoarseness]], [[dysphagia]], [[osteoporosis|bone mineral loss]] and [[thyroid storm]]. Prognosis of toxic multinodular goiter is generally good with treatment. Both [[surgery]] and [[radioactive iodine]] therapy can confer a moderate long-term risk of [[hypothyroidism]] and such patients require lifelong [[hormone]] replacement [[therapy]]. Toxic multinodular goiter is commonly seen in elderly. Therefore, in elderly, presence of other conditions may influence the outcome of toxic multinodular goiter.


==Overview==
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural History===
===Natural History===
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.  
*If left untreated, toxic multinodular goiter may progress to develop [[hyperthyroidism]].<ref name="pmid582300">{{cite journal |vauthors=Wiener JD, de Vries AA |title=On the natural history of Plummer's disease |journal=Clin Nucl Med |volume=4 |issue=5 |pages=181–90 |year=1979 |pmid=582300 |doi= |url=}}</ref><ref name="pmid2114018">{{cite journal |vauthors=Elte JW, Bussemaker JK, Haak A |title=The natural history of euthyroid multinodular goitre |journal=Postgrad Med J |volume=66 |issue=773 |pages=186–90 |year=1990 |pmid=2114018 |pmc=2429462 |doi= |url=}}</ref><ref name="pmid11567699">{{cite journal |vauthors=Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA |title=Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study |journal=Lancet |volume=358 |issue=9285 |pages=861–5 |year=2001 |pmid=11567699 |doi=10.1016/S0140-6736(01)06067-6 |url=}}</ref><ref name="pmid15145238">{{cite journal |vauthors=Pearce EN, Braverman LE |title=Hyperthyroidism: advantages and disadvantages of medical therapy |journal=Surg. Clin. North Am. |volume=84 |issue=3 |pages=833–47 |year=2004 |pmid=15145238 |doi=10.1016/j.suc.2004.01.007 |url=}}</ref>
*The symptoms of (disease name) typically develop ___ years after exposure to ___.  
*Untreated toxic multinodular goiter progresses slowly and initially presents with history of [[thyroid]] enlargement.
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*[[Thyroid]] enlargement is followed by a long period of subclinical hyperthyroidism.
*Overt [[hyperthyroidism]] occurs late in the course of toxic multinodular goiter.
**When [[hyperthyroidism]] is present, cardiac symptoms are the most common presentation such as [[palpitations]], [[tachycardia]], [[heart failure]] and [[atrial fibrillation]].
** Over the course of time,  toxic multinodular goiter may increase in size and can lead to compression of surrounding structures such as [[trachea]], [[esophagus]] or [[external jugular vein]].


===Complications===
===Complications===
*Common complications of [disease name] include:
Common complications of toxic multinodular goiter include:<ref name="pmid18752767">{{cite journal |vauthors=Dahl P, Danzi S, Klein I |title=Thyrotoxic cardiac disease |journal=Curr Heart Fail Rep |volume=5 |issue=3 |pages=170–6 |year=2008 |pmid=18752767 |doi= |url=}}</ref><ref name="pmid24273583">{{cite journal |vauthors=Ertek S, Cicero AF |title=Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology |journal=Arch Med Sci |volume=9 |issue=5 |pages=944–52 |year=2013 |pmid=24273583 |pmc=3832836 |doi=10.5114/aoms.2013.38685 |url=}}</ref>
**[complication 1]
*[[Tachycardia]]
**[complication 2]
*[[Arrhythmia]]
**[complication 3]
*[[Atrial fibrillation]]
*[[Heart failure]] ([[dilated cardiomyopathy]])
*[[Pulmonary hypertension]]
*Facial [[plethora]]
*Inspiratory [[stridor]]
*[[Hoarseness]]
*[[Dysphagia]]
*[[Osteoporosis|Bone mineral loss]]
*[[Thyroid storm]]
*[[Iodine-131|I-131]]-related hypothyroidism
*Surgery-related
**[[Hypothyroidism]]  
**Recurrent [[Laryngeal nerve palsy|laryngeal nerve damage]]
**[[Hypoparathyroidism]]


===Prognosis===
===Prognosis===
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
*Prognosis of toxic multinodular goiter is generally good with treatment.
*Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
*About 45% to 75% of patients stay [[euthyroid]] following [[I-123 thyroid imaging|I-131]] therapy.
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
*Both surgery and [[radioactive iodine]] therapy can confer a moderate long-term risk of [[hypothyroidism]].
*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
*Patients with [[I-123 thyroid imaging|I-131]] therapy who develop hypothyroidism require lifelong thyroid hormone replacement therapy
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
*Toxic multinodular goiter is commonly seen in elderly. Therefore, in elderly, presence of other conditions may influence the outcome of toxic multinodular goiter.


==References==
==References==

Latest revision as of 12:16, 17 October 2017

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter natural history, complications and prognosis

CDC on Toxic multinodular goiter natural history, complications and prognosis

Toxic multinodular goiter natural history, complications and prognosis in the news

Blogs on Toxic multinodular goiter natural history, complications and prognosis

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

If left untreated, toxic multinodular goiter may progress to develop hyperthyroidism. However, the progression of toxic multinodular goiter is quite slow. Untreated patients initially have a history of thyroid enlargement followed by a long period of subclinical hyperthyroidism. Overt hyperthyroidism occurs late in the course of toxic multinodular goiter. Common complications of toxic multinodular goiter include tachycardia, arrhythmia, atrial fibrillation, heart failure (dilated cardiomyopathy), pulmonary hypertension, facial plethora, inspiratory stridor, hoarseness, dysphagia, bone mineral loss and thyroid storm. Prognosis of toxic multinodular goiter is generally good with treatment. Both surgery and radioactive iodine therapy can confer a moderate long-term risk of hypothyroidism and such patients require lifelong hormone replacement therapy. Toxic multinodular goiter is commonly seen in elderly. Therefore, in elderly, presence of other conditions may influence the outcome of toxic multinodular goiter.

Natural History, Complications, and Prognosis

Natural History

Complications

Common complications of toxic multinodular goiter include:[5][6]

Prognosis

  • Prognosis of toxic multinodular goiter is generally good with treatment.
  • About 45% to 75% of patients stay euthyroid following I-131 therapy.
  • Both surgery and radioactive iodine therapy can confer a moderate long-term risk of hypothyroidism.
  • Patients with I-131 therapy who develop hypothyroidism require lifelong thyroid hormone replacement therapy
  • Toxic multinodular goiter is commonly seen in elderly. Therefore, in elderly, presence of other conditions may influence the outcome of toxic multinodular goiter.

References

  1. Wiener JD, de Vries AA (1979). "On the natural history of Plummer's disease". Clin Nucl Med. 4 (5): 181–90. PMID 582300.
  2. Elte JW, Bussemaker JK, Haak A (1990). "The natural history of euthyroid multinodular goitre". Postgrad Med J. 66 (773): 186–90. PMC 2429462. PMID 2114018.
  3. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA (2001). "Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study". Lancet. 358 (9285): 861–5. doi:10.1016/S0140-6736(01)06067-6. PMID 11567699.
  4. Pearce EN, Braverman LE (2004). "Hyperthyroidism: advantages and disadvantages of medical therapy". Surg. Clin. North Am. 84 (3): 833–47. doi:10.1016/j.suc.2004.01.007. PMID 15145238.
  5. Dahl P, Danzi S, Klein I (2008). "Thyrotoxic cardiac disease". Curr Heart Fail Rep. 5 (3): 170–6. PMID 18752767.
  6. Ertek S, Cicero AF (2013). "Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology". Arch Med Sci. 9 (5): 944–52. doi:10.5114/aoms.2013.38685. PMC 3832836. PMID 24273583.

Template:WH Template:WS